Table 3. Multivariate analysis of prognostic factors and risk stratification by combination of KPS⩽70%, moderate or severe lung disease and eGFR<30.
Comorbidity factors | Definition | n | HR (95% Confidence interval) | P-valuea |
---|---|---|---|---|
KPS | >70% | 88 | 2.17 (1.23–3.82) | 0.0077 |
⩽70% | 39 | |||
Lung disease | No/mild | 104 | 2.78 (1.53–5.04) | 0.0008 |
Moderate/severe | 23 | |||
eGFRMDRD (ml/min/1.73m2) | ⩾30 | 115 | 2.93 (1.33–6.46) | 0.0075 |
<30 | 12 | |||
FCI |
Median OS (months) |
n |
HR (95% Confidence interval) |
P-valuea |
0 | 118 | 74 | 1.0 (reference) | — |
1 | 53 | 36 | 2.5 (1.4–4.5) | 0.0033 |
2 or 3 | 25 | 17 | 6.5 (3.2–13.2) | < 0.0001 |
Abbreviations: eGFRMDRD, estimated glomerular filtration rate by MDRD (Modification of Diet in Renal Disease); FCI, Freiburger comorbidity index; HR, hazard ratio; KPS, Karnofsky Performance Status; OS, overall survival.
χ2-test.